Reneuron Group (RENE)

 

Latest News

ReNeuron presents positive exosome data

ReNeuron Group will be presenting new positive pre-clinical data relating to its ExoPr0 CTX cell-derived exosome therapy...

Presents positive exosome data at major conference

RNS Number: 4700F ReNeuron Group plc 18 May 2017 AIM: RENE 18 May 2017 ReNeuron Group plc ReNeuron presents positive pre-clinical data with its ExoPr0 exosome therapy candidate at major scientific conference Data show that ExoPr0 can cross the blood brain barrier and can potentially target multiple diseases via local or systemic administration ReNeur...

ReNeuron awarded £1.8m grant from Innovate UK

ReNeuron Group has been awarded a 1.8m grant from Innovate UK to further advance its next generation commercial ce...

Awarded major UK cell therapy manufacturing grant

RNS Number: 7818E ReNeuron Group plc 11 May 2017 AIM: RENE 11 May 2017 ReNeuron Group plc ReNeuron awarded major UK cell therapy manufacturing grant ReNeuron Group plc (the "Company") (AIM: RENE), a leading UK-based stem cell therapy development company, is pleased to announce that it has been awarded a 1.8 million grant from Innovate U...

All News

DateHeadlineSource
18-05-17ReNeuron presents positive exosome dataStockMarketWire
18-05-17Presents positive exosome data at major conferenceRNS
11-05-17ReNeuron awarded £1.8m grant from Innovate UKStockMarketWire
11-05-17Awarded major UK cell therapy manufacturing grantRNS
05-05-17Presents new exosome data at major conferenceRNS
21-04-17ReNeuron updates on ophthalmology programmesStockMarketWire
21-04-17ReNeuron updates on clinical strategy in stroke disabilityStockMarketWire
21-04-17Update on clinical strategy in stroke disabilityRNS
21-04-17Update on progress in ophthalmology programmesRNS
01-03-17Block Listing Review and Total Voting RightsRNS
15-02-17ReNeuron featured in BBC documentaryRNS
07-02-17Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
07-02-17Director Share PurchaseRNS
01-02-17ReNeuron Group to present at the Shares Spotlight Evening in Edinburgh on 15 February 2017StockMarketWire
14-12-16Director Share PurchaseRNS
05-12-16ReNeuron widens H1 pretax lossStockMarketWire
05-12-16ReNeuron reports positive results in Phase II Stroke TrialStockMarketWire
05-12-16Interim ResultsRNS
05-12-16Reports Positive Results in Phase II Stroke TrialRNS
14-11-16Notification of Interim ResultsRNS
14-10-16ReNeuron Group Plc to present at the Shares Investor Evening in London on 27th October 2016StockMarketWire
05-10-16Notification of Major Interest in SharesRNS
22-09-16Block Listing Review and Total Voting RightsRNS
06-09-16ReNeuron passes AGM resolutionsStockMarketWire
06-09-16Result of AGMRNS
06-09-16AGM Trading UpdateRNS
05-08-16Posting of Annual Report and Notice of AGMRNS
04-08-16Stroke clinical data published in The LancetRNS
22-07-16Publication of positive pre-clinical retinal dataRNS
20-07-16Directors' Interest in Shares and Share OptionsRNS
07-07-16Preliminary ResultsRNS
14-06-16Notification of Preliminary ResultsRNS
13-06-16Reuron says patient recruitment completed in stroke trial StockMarketWire
13-06-16Patient recruitment completed in stroke trialRNS
09-06-16ReNeuron pursues brain cancer with exosome platform StockMarketWire
09-06-16Pursues brain cancer with exosome platformRNS
08-06-16ReNeuron Group gives Retinitis pigmentosa update StockMarketWire
08-06-16Retinitis pigmentosa update & Notice of KOL eventRNS
31-05-16Change of AdviserRNS
21-03-16Are Today’s Double-Digit Rises Just The Start For Filtronic Plc, Angle plc And ReNeuron Group Plc?Motley Fool

RSS feeds

  • Editorial news feed for LSE:RENE Editorial
  • Regulatory news feed for LSE:RENE Regulatory